Double-edged swords as cancer therapeutics: Novel, orally active, small molecules simultaneously inhibit p53-MDM2 interaction and the NF-κB pathway

Chunlin Zhuang, Zhenyuan Miao, Yuelin Wu, Zizhao Guo, Jin Li, Jianzhong Yao, Chengguo Xing, Chunquan Sheng, Wannian Zhang

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Double-edged swords as cancer therapeutics: Novel, orally active, small molecules simultaneously inhibit p53-MDM2 interaction and the NF-κB pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds